What is BioCryst Pharmaceuticals Inc?
, a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.86B.
A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 4273,613 shares $2.6M | 0 |
| 9-12months | 5204,663 shares $1.5M | 0 |